Specific TP53 subtype as biomarker for immune checkpoint inhibitors in lung adenocarcinoma.
EBioMedicine
; 60: 102990, 2020 Oct.
Article
in En
| MEDLINE
| ID: mdl-32927274
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Biomarkers, Tumor
/
Tumor Suppressor Protein p53
/
Adenocarcinoma of Lung
/
Mutation
Type of study:
Clinical_trials
/
Prognostic_studies
Limits:
Humans
Language:
En
Journal:
EBioMedicine
Year:
2020
Type:
Article
Affiliation country:
China